DiagnaMed Sees Brain Age AI Platform Validated In Peer-Reviewed Paper
DiagnaMed Holdings (CSE: DMED) is reporting this morning that its flagship Brain Age Brain Health AI Platform has obtained the status of being clinically validated, following the publishing of a peer-reviewed paper.
Read more